AstraZeneca Group
page
1
of
1
FTSE 100 shares close lower
Mar 21, 2013 13:18 EDT
London shares closed lower on Thursday as traders looked past positive economic data to focus on bleak eurozone news, notably fallout from the Cyprus bailout impasse.
Drugmaker AstraZeneca announces 2,300 more job cuts
Mar 21, 2013 06:01 EDT
British pharmaceutical company AstraZeneca on Thursday said it was cutting 2,300 jobs on top of the 1,600 losses it announced at the start of the week, in a major restructuring of the group over the next three years.
Drugmaker AstraZeneca says to cut 1,600 jobs
Mar 18, 2013 11:08 EDT
British pharmaceutical company AstraZeneca on Monday said it would axe 1,600 jobs worldwide in a major restructuring of the group over the next three years.
FTSE ends lower on US, company news
Jan 31, 2013 12:51 EST
London shares closed lower on Thursday as dealers fretted over the shrinking US economy and a flood of company earnings news, analysts said.
Drugs giant AstraZeneca posts 37% profit drop
Jan 31, 2013 05:37 EST
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that net profits sank 37 percent last year, hit by the expiry of drug patents and "tough" markets, and warned revenues would fall further in 2013.
London shares close flat before busy earnings week
Jan 28, 2013 12:39 EST
London shares closed little changed on Monday as investors cashed in on recent major gains or kept to the sidelines ahead of a busy week for UK company results, dealers said.
London shares close lower on fiscal cliff concerns
Dec 13, 2012 12:24 EST
London shares closed lower on Thursday amid renewed worries about lack of progress in talks to avert the US fiscal cliff, dealers said.
London shares close flat amid 'fiscal cliff' fears
Nov 28, 2012 12:35 EST
London shares closed flat on Wednesday amid renewed concern about the looming "fiscal cliff" of automatic tax rises and spending cuts which threatens to send the United States back into recession, dealers said.
India rejects AstraZeneca patent appeal
Nov 28, 2012 08:16 EST
An Indian panel has rejected an appeal by Britain's AstraZeneca against a decision to deny patent protection to a cancer-fighting drug in a new setback for global drug firms in the Indian market.
London shares close higher as mega merger revived
Oct 01, 2012 12:28 EDT
London shares closed higher on Monday following the revival of a merger bid by commodities sector giants Xstrata and Glencore.
AstraZeneca profits dive on patent expiries
Jul 26, 2012 05:39 EDT
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that second-quarter profits sank, hit by the expiry of key drug patents, tough conditions and competition from generic drugmakers.
Advertiser WPP hit by shareholder revolt over boss' pay
Jun 13, 2012 12:25 EDT
Global advertising giant WPP suffered a major revolt by shareholders on Wednesday as almost 60 percent of investors voted against the company's latest remuneration report, it revealed.
Aviva chief exec resigns after shareholder revolt
May 08, 2012 04:44 EDT
The chief executive of Britain's second-biggest insurance group Aviva stepped down on Tuesday, becoming the latest victim of a growing shareholder revolt over pay for top managers.
Insurer Aviva's CEO resigns after shareholder revolt
May 08, 2012 04:20 EDT
The chief executive of Britain's second-biggest insurance group Aviva stepped down on Tuesday, becoming the latest victim of a growing shareholder revolt over pay for top managers.
Shareholders revolt over bumper boardroom pay in Britain
May 06, 2012 07:01 EDT
Top British companies face a wave of investor activism as shareholders rebel over boardroom pay, amid under-performance in the poor economic climate and state moves to clamp down on corporate greed.
Indian drug giant Cipla slashes cancer drug prices
May 04, 2012 12:39 EDT
Indian generic drug giant Cipla said Friday it had slashed by up to 76 percent prices of three anti-cancer medicines in what it called a "humanitarian" move and promised to cut the costs of more products.
European stocks close mixed
Apr 26, 2012 12:57 EDT
European stock markets closed mixed Thursday as flat US jobs data and weak earnings from major banks offset any positive impact from the US Federal Reserve's latest economic outlook.
London shares rise, lifted by company results
Apr 26, 2012 12:20 EDT
London shares closed higher on Thursday, boosted by strong corporate results, traders said.
European stocks lower on poor bank earnings
Apr 26, 2012 07:32 EDT
European stock markets were mostly lower on Thursday on downbeat earnings from major banks while the euro rose against the dollar after the US Federal Reserve's latest economic outlook, traders said.
AstraZeneca boss to retire as profits tumble
Apr 26, 2012 04:52 EDT
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that net profits nosedived by 44 percent in the first quarter and announced the exit of chief executive David Brennan.
